Patterson Companies, Inc. (Nasdaq: PDCO) today reported consolidated net sales of approximately $1.4 billion (see attached Sales Summary for further details) in its fiscal fourth quarter ended April 28, 2018, a decline of 3.1 percent compared to the same period last year. Internal sales, which adjust for the effects of currency translation and changes in product selling relationships, declined 3.3 percent.
Reported net income from continuing operations for the fourth quarter of fiscal year 2018 was $20.9 million, or $0.23 per diluted share, compared to $61.4 million, or $0.65 per diluted share, in last year’s fiscal fourth quarter.
Adjusted net income1 from continuing operations, which excludes deal amortization costs and discrete tax matters, totaled $28.2 million for the fourth quarter of fiscal 2018, compared to $65.6 million in the same quarter last year, driven by the anticipated decrease in sales and margins in our Dental segment and a change in estimate related to year-end inventory valuations. Adjusted earnings1 per diluted share from continuing operations totaled $0.30 in the fourth quarter, compared to $0.69 in the fiscal 2017 fourth quarter.
“Our fourth-quarter results met our revised expectations and reflected the impact of ongoing challenges that the Company has been facing,” said Mark Walchirk, president and CEO of Patterson Companies. “Looking ahead, we are executing on a number of initiatives to stabilize the core business and build a stronger platform for fiscal 2019, and expect to return to profit growth in the second half of the year. These initiatives are focused on improving our revenue, margin and cash flow performance and unlocking the strength of our value proposition. We are confident that we are taking the right steps to improve performance and deliver shareholder value going forward.”
Patterson Dental
Reported net sales in our Dental segment
for the fourth quarter, which represented approximately 39 percent of
total company sales, were $545.8 million compared to $607.3 million in
the same quarter last year. Internal sales declined 10.5 percent
compared to the fiscal 2017 fourth quarter. Year-over-year internal
sales by category were as follows:
- Consumable dental supplies decreased 6.7 percent.
- Equipment and software declined 20.2 percent.
- Other services and products, primarily composed of technical service, parts and labor, software support services and office supplies decreased 2.5 percent.
“As expected, results in the Dental segment reflected the continued challenges throughout the year as a result of our sales force realignment, ERP implementation and the market transition in the digital equipment category,” continued Walchirk. “We are focused on improving sales productivity, strengthening product mix, leveraging our new ERP platform and expanding our sales penetration in the digital equipment market. We expect these actions will contribute toward stabilizing the Dental business and building momentum around growth and profitability in the second half of fiscal 2019.”
Patterson Animal Health
Reported net sales in our Animal
Health segment for the fourth quarter of fiscal 2018, which comprised
approximately 61 percent of the company’s total sales, were $848.0
million compared to $827.5 in the same quarter last year. Internal sales
for the segment increased 2.4 percent from the fiscal 2017 fourth
quarter. Year-over-year internal sales by category were as follows:
- Production animal increased 2.8 percent.
- Companion animal rose 1.9 percent.
“Sales in our Animal Health segment grew as expected in the quarter, led by our production animal health business, which benefitted from improving fundamentals in the swine and beef categories, partially offset by pressures in the dairy category,” continued Walchirk. “In fiscal 2019, we expect to improve growth and operating performance in the Animal Health business through driving sales execution, improved product mix and effective cost management.”
Share Repurchases and Dividends
In the fourth quarter of
fiscal 2018, Patterson paid $24.6 million in cash dividends to
shareholders. For fiscal 2018, the company returned a total of $186.7
million to shareholders in the form of share repurchases and dividends.
Year-to-Date Results
Consolidated sales for fiscal 2018
totaled $5.5 billion, a 2.3 percent year-over-year decrease. Internal
sales declined 1.6 percent. Reported net income from continuing
operations was $201.0 million, or $2.16 per diluted share, compared
to $173.8 million, or $1.82 per diluted share in fiscal 2017. This
comparison includes the recognition of a provisional net tax benefit of
$76.6 million, reflecting the revaluation of tax-deferred assets and
liabilities, net of a one-time transition tax on unremitted foreign
earnings as a result of the 2017 Tax Act enacted during the third
quarter. Fiscal 2017 results contained a pre-tax non-cash impairment
charge of approximately $36 million, or approximately $23 million after
taxes, or $0.24 per diluted share, related to the distribution fee
associated with the CEREC product component of the previously exclusive
arrangement with Sirona Dental Systems.
Adjusted net income1 from continuing operations, which excludes transaction-related costs, deal amortization costs, intangible asset impairment, integration and business restructuring expenses, and discrete tax matters, totaled $156.8 million, or $1.68 per diluted share, compared to $223.3 million, or $2.34 per diluted share, in fiscal 2017.
FY2019 Guidance
Patterson today issued fiscal 2019 earnings
guidance from continuing operations, which is provided on both a GAAP
and non-GAAP adjusted1 basis:
- GAAP earnings from continuing operations are expected to be in the range of $1.43 to $1.53 per diluted share.
- Non-GAAP adjusted earnings1 from continuing operations are expected to be in the range of $1.73 to $1.83 per diluted share.
- Our non-GAAP adjusted earnings1 guidance excludes the after-tax impact of deal amortization expense of approximately $27.3 million ($0.30 per diluted share).
Our guidance is for current continuing operations as well as completed or previously announced acquisitions and does not include the impact of potential future acquisitions or similar transactions, if any, or impairments and material restructurings beyond those previously publicly disclosed. Our guidance assumes North American and international market conditions similar to those experienced in fiscal 2018.
1Non-GAAP Financial Measures
The
Reconciliation of GAAP to non-GAAP Measures table appearing behind the
accompanying financial information is provided to adjust reported GAAP
measures, namely earnings from continuing operations, net income from
continuing operations and earnings per diluted share from continuing
operations, for the impact of transaction related costs, deal
amortization expenses, intangible asset impairment, integration and
business restructuring expenses, along with the related tax effects of
these items, the impact of the 2017 Tax Act and other discrete tax
matters.
Management believes that these non-GAAP measures may provide a helpful representation of the company's fourth-quarter and full-year performance and earnings guidance, and enable comparison of financial results between periods where certain items may vary independent of business performance. These non-GAAP financial measures are presented solely for informational and comparative purposes and should not be regarded as a replacement for corresponding, similarly captioned, GAAP measures.
In addition, the term constant currency represents net sales adjusted to exclude foreign currency impacts. Foreign currency impact represents the difference in results that is attributable to fluctuations in currency exchange rates the company uses to convert results for all foreign entities where the functional currency is not the U.S. dollar. The company calculates the impact as the difference between the current period results translated using the current period currency exchange rates and using the comparable prior period's currency exchange rates. The company believes the disclosure of net sales changes in constant currency provides useful supplementary information to investors in light of significant fluctuations in currency rates.
Fourth-Quarter Conference Call and Replay
Patterson’s
fourth-quarter earnings conference call will start at 10 a.m. Eastern
today. Investors can listen to a live webcast of the conference call at www.pattersoncompanies.com.
The conference call will be archived on Patterson’s website. A replay of
the fiscal 2018 fourth-quarter conference call can be heard for one week
at 800-585-8367 and by providing the Conference ID 4897286 when prompted.
About Patterson Companies Inc.
Patterson Companies
Inc. (Nasdaq: PDCO) is a value-added distributor serving the dental and
animal health markets.
Dental Market
Patterson’s Dental
segment provides a virtually complete range of consumable dental
products, equipment and software, turnkey digital solutions and
value-added services to dentists and dental laboratories
throughout North America.
Animal Health Market
Patterson’s Animal
Health segment is a leading distributor of products, services and
technologies to both the production and companion animal health markets
in North America and the U.K.
This press release contains certain forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements are information of a non-historical nature and are subject to risks and uncertainties that are beyond Patterson's ability to control. Forward-looking statements generally can be identified by words such as "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. It is uncertain whether any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do, what impact they will have on the results of operations and financial condition of Patterson or the price of Patterson stock. These forward-looking statements involve certain risks and uncertainties that could cause actual results to differ materially from those indicated in such forward-looking statements. Such risks and uncertainties include, without limitation, operations disruptions attributable to our enterprise resource planning system implementation; our ability to attract or retain qualified sales representatives and service technicians who relate directly with our customers; the reduction, modification, cancellation or delay of purchases of innovative, high-margin equipment; material changes in our purchasing relationships with suppliers; changes in general market and economic conditions; and the other risks and important factors contained and identified in Patterson's filings with the Securities and Exchange Commission, such as its Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K, any of which could cause actual results to differ materially from the forward-looking statements. Any forward-looking statement in this press release speaks only as of the date on which it is made. Except to the extent required under the federal securities laws, Patterson does not intend to update or revise the forward-looking statements.
PATTERSON COMPANIES, INC. | |||||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF INCOME | |||||||||||||||||
(In thousands, except per share amounts) | |||||||||||||||||
(Unaudited) | |||||||||||||||||
Three Months Ended | Twelve Months Ended | ||||||||||||||||
April 28, |
April 29, |
April 28, |
April 29, | ||||||||||||||
Net sales | $ | 1,400,609 | $ | 1,445,032 | $ | 5,465,683 | $ | 5,593,127 | |||||||||
Gross profit | 289,839 | 335,498 | 1,199,366 | 1,301,397 | |||||||||||||
Operating expenses | 248,588 | 239,343 | 979,477 | 1,013,469 | |||||||||||||
Operating income from continuing operations | 41,251 | 96,155 | 219,889 | 287,928 | |||||||||||||
Other income (expense): | |||||||||||||||||
Other income, net | 1,349 | 1,033 | 6,117 | 6,013 | |||||||||||||
Interest expense | (12,289) | (11,401) | (46,743) | (43,060) | |||||||||||||
Income from continuing operations before taxes | 30,311 | 85,787 | 179,263 | 250,881 | |||||||||||||
Income tax expense (benefit) | 9,383 | 24,430 | (21,711) | 77,093 | |||||||||||||
Net income from continuing operations | 20,928 | 61,357 | 200,974 | 173,788 | |||||||||||||
Net loss from discontinued operations | - | 334 | - | (2,895) | |||||||||||||
Net income | $ | 20,928 | $ | 61,691 | $ | 200,974 | $ | 170,893 | |||||||||
Basic earnings (loss) per share: | |||||||||||||||||
Continuing operations | $ | 0.23 | $ | 0.65 | $ | 2.17 | $ | 1.83 | |||||||||
Discontinued operations | - | 0.01 | - | (0.03) | |||||||||||||
Net basic earnings per share | $ | 0.23 | $ | 0.66 | $ | 2.17 | $ | 1.80 | |||||||||
Diluted earnings (loss) per share: | |||||||||||||||||
Continuing operations | $ | 0.23 | $ | 0.65 | $ | 2.16 | $ | 1.82 | |||||||||
Discontinued operations | - | - | - | (0.03) | |||||||||||||
Net diluted earnings per share | $ | 0.23 | $ | 0.65 | $ | 2.16 | $ | 1.79 | |||||||||
Weighted average shares: | |||||||||||||||||
Basic | 91,846 | 93,830 | 92,467 | 94,897 | |||||||||||||
Diluted | 92,446 | 94,503 | 93,094 | 95,567 | |||||||||||||
Dividends declared per common share | $ | 0.26 | $ | 0.26 | $ | 1.04 | $ | 0.98 | |||||||||
PATTERSON COMPANIES, INC. | |||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | |||||||||
(In thousands) | |||||||||
(Unaudited) | |||||||||
April 28, |
April 29, | ||||||||
ASSETS | |||||||||
Current assets: | |||||||||
Cash and cash equivalents | $ | 62,984 | $ | 94,959 | |||||
Receivables | 826,877 | 884,803 | |||||||
Inventory | 779,834 | 711,903 | |||||||
Prepaid expenses and other current assets | 103,029 | 111,928 | |||||||
Total current assets | 1,772,724 | 1,803,593 | |||||||
Property and equipment, net | 290,590 | 298,452 | |||||||
Goodwill and other intangible assets | 1,205,401 | 1,238,983 | |||||||
Long-term receivables, net and other | 202,949 | 166,885 | |||||||
Total assets | $ | 3,471,664 | $ | 3,507,913 | |||||
LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||||
Current liabilities: | |||||||||
Accounts payable | $ | 610,368 | $ | 616,859 | |||||
Other accrued liabilities | 205,415 | 213,318 | |||||||
Current maturities of long-term debt | 76,598 | 14,754 | |||||||
Borrowings on revolving credit | 16,000 | 59,000 | |||||||
Total current liabilities | 908,381 | 903,931 | |||||||
Long-term debt | 922,030 | 998,272 | |||||||
Other non-current liabilities | 179,463 | 211,277 | |||||||
Total liabilities | 2,009,874 | 2,113,480 | |||||||
Stockholders' equity | 1,461,790 | 1,394,433 | |||||||
Total liabilities and stockholders' equity | $ | 3,471,664 | $ | 3,507,913 | |||||
PATTERSON COMPANIES, INC. | |||||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | |||||||||
(In thousands) | |||||||||
(Unaudited) | |||||||||
Twelve Months Ended | |||||||||
April 28, |
April 29, | ||||||||
Operating activities: | |||||||||
Net income | $ | 200,974 | $ | 170,893 | |||||
Net loss from discontinued operations | - | (2,895) | |||||||
Net income from continuing operations | 200,974 | 173,788 | |||||||
Adjustments to reconcile net income from continuing operations to net cash provided by operating activities: | |||||||||
Depreciation and amortization | 83,816 | 83,818 | |||||||
Intangible asset impairment | - | 36,312 | |||||||
Non-cash employee compensation | 36,532 | 19,025 | |||||||
Change in assets and liabilities, net of acquired | (142,427) | (147,329) | |||||||
Net cash provided by operating activities- continuing operations | 178,895 | 165,614 | |||||||
Net cash used in operating activities- discontinued operations | - | (2,895) | |||||||
Net cash provided by operating activities | 178,895 | 162,719 | |||||||
Investing activities: | |||||||||
Additions to property and equipment | (43,263) | (47,019) | |||||||
Collection of deferred purchase price receivables | 49,650 | 51,402 | |||||||
Other investing activities | 10,600 | (3,190) | |||||||
Net cash provided by investing activities- continuing operations | 16,987 | 1,193 | |||||||
Net cash provided by investing activities- discontinued operations | - | - | |||||||
Net cash provided by investing activities | 16,987 | 1,193 | |||||||
Financing activities: | |||||||||
Dividends paid | (99,199) | (95,910) | |||||||
Repurchases of common stock | (87,500) | (125,384) | |||||||
Proceeds from issuance of long-term debt, net | 150,000 | - | |||||||
Debt amendment costs | - | (1,266) | |||||||
Retirement of long-term debt | (164,754) | (26,238) | |||||||
Draw on (payment on) revolver | (43,000) | 39,000 | |||||||
Other financing activities | 14,291 | 7,635 | |||||||
Net cash used in financing activities | (230,162) | (202,163) | |||||||
Effect of exchange rate changes on cash | 2,305 | (4,243) | |||||||
Net change in cash and cash equivalents | $ | (31,975) | $ | (42,494) | |||||
PATTERSON COMPANIES, INC. | |||||||||||||||||||||||||
SALES SUMMARY | |||||||||||||||||||||||||
(Dollars in thousands) | |||||||||||||||||||||||||
(Unaudited) | |||||||||||||||||||||||||
April 28, |
April 29, |
Total |
Foreign | Other (a) |
Internal | ||||||||||||||||||||
Three Months Ended | |||||||||||||||||||||||||
Consolidated net sales | |||||||||||||||||||||||||
Consumable | $ | 1,145,258 | $ | 1,148,337 | (0.3) | % | 1.7 | % | (1.5) | % | (0.5) | % | |||||||||||||
Equipment and software | 168,393 | 207,339 | (18.8) | 0.4 | - | (19.2) | |||||||||||||||||||
Other | 86,958 | 89,356 | (2.7) | 0.8 | - | (3.5) | |||||||||||||||||||
Total | $ | 1,400,609 | $ | 1,445,032 | (3.1) | % | 1.4 | % | (1.2) | % | (3.3) | % | |||||||||||||
Dental | |||||||||||||||||||||||||
Consumable | $ | 317,951 | $ | 339,398 | (6.3) | % | 0.4 | % | - | % | (6.7) | % | |||||||||||||
Equipment and software | 155,979 | 194,493 | (19.8) | 0.4 | - | (20.2) | |||||||||||||||||||
Other | 71,834 | 73,417 | (2.2) | 0.3 | - | (2.5) | |||||||||||||||||||
Total | $ | 545,764 | $ | 607,308 | (10.1) | % | 0.4 | % | - | % | (10.5) | % | |||||||||||||
Animal Health | |||||||||||||||||||||||||
Consumable | $ | 827,307 | $ | 808,939 | 2.3 | % | 2.2 | % | (2.1) | % | 2.2 | % | |||||||||||||
Equipment and software | 12,414 | 12,846 | (3.4) | 0.1 | - | (3.5) | |||||||||||||||||||
Other | 8,257 | 5,687 | 45.2 | 7.9 | - | 37.3 | |||||||||||||||||||
Total | $ | 847,978 | $ | 827,472 | 2.5 | % | 2.2 | % | (2.1) | % | 2.4 | % | |||||||||||||
Corporate | |||||||||||||||||||||||||
Other | $ | 6,867 | $ | 10,252 | (33.0) | % | - | % | - | % | (33.0) | % | |||||||||||||
Total | $ | 6,867 | $ | 10,252 | (33.0) | % | - | % | - | % | (33.0) | % | |||||||||||||
Twelve Months Ended | |||||||||||||||||||||||||
Consolidated net sales | |||||||||||||||||||||||||
Consumable | $ | 4,415,643 | $ | 4,400,888 | 0.3 | % | 0.6 | % | (1.5) | % | 1.2 | % | |||||||||||||
Equipment and software | 709,253 | 834,526 | (15.0) | 0.3 | - | (15.3) | |||||||||||||||||||
Other | 340,787 | 357,713 | (4.7) | 0.3 | - | (5.0) | |||||||||||||||||||
Total | $ | 5,465,683 | $ | 5,593,127 | (2.3) | % | 0.5 | % | (1.2) | % | (1.6) | % | |||||||||||||
Dental | |||||||||||||||||||||||||
Consumable | $ | 1,251,642 | $ | 1,321,764 | (5.3) | % | 0.3 | % | - | % | (5.6) | % | |||||||||||||
Equipment and software | 660,355 | 780,868 | (15.4) | 0.3 | - | (15.7) | |||||||||||||||||||
Other | 284,081 | 287,587 | (1.2) | 0.2 | - | (1.4) | |||||||||||||||||||
Total | $ | 2,196,078 | $ | 2,390,219 | (8.1) | % | 0.3 | % | - | % | (8.4) | % | |||||||||||||
Animal Health | |||||||||||||||||||||||||
Consumable | $ | 3,164,001 | $ | 3,079,124 | 2.8 | % | 0.7 | % | (2.1) | % | 4.2 | % | |||||||||||||
Equipment and software | 48,898 | 53,658 | (8.9) | - | - | (8.9) | |||||||||||||||||||
Other | 29,665 | 27,044 | 9.7 | 1.7 | - | 8.0 | |||||||||||||||||||
Total | $ | 3,242,564 | $ | 3,159,826 | 2.6 | % | 0.7 | % | (2.1) | % | 4.0 | % | |||||||||||||
Corporate | |||||||||||||||||||||||||
Other | $ | 27,041 | $ | 43,082 | (37.2) | % | - | % | - | % | (37.2) | % | |||||||||||||
Total | $ | 27,041 | $ | 43,082 | (37.2) | % | - | % | - | % | (37.2) | % | |||||||||||||
(a) Sales of certain products previously recognized on a gross basis were recognized on a net basis during the three and twelve months ended April 28, 2018. |
PATTERSON COMPANIES, INC. | |||||||||||||||||
OPERATING INCOME BY SEGMENT | |||||||||||||||||
(In thousands) | |||||||||||||||||
(Unaudited) | |||||||||||||||||
Three Months Ended | Twelve Months Ended | ||||||||||||||||
April 28, |
April 29, |
April 28, |
April 29, | ||||||||||||||
Operating income (loss) | |||||||||||||||||
Dental | $ | 46,036 | $ | 86,315 | $ | 229,201 | $ | 263,671 | |||||||||
Animal Health | 20,128 | 27,672 | 78,058 | 88,132 | |||||||||||||
Corporate | (24,913) | (17,832) | (87,370) | (63,875) | |||||||||||||
Total | $ | 41,251 | $ | 96,155 | $ | 219,889 | $ | 287,928 | |||||||||
PATTERSON COMPANIES, INC. | |||||||||||||||||||||||||||||
RECONCILIATION OF GAAP TO NON-GAAP MEASURES | |||||||||||||||||||||||||||||
(Dollars in thousands, except per share amounts) | |||||||||||||||||||||||||||||
(Unaudited) | |||||||||||||||||||||||||||||
For the three months ended April 28, 2018 | GAAP | Transaction- |
Deal |
Intangible |
Integration |
Discrete |
Non- | ||||||||||||||||||||||
Operating income from continuing operations | $ | 41,251 | $ | — | $ | 9,533 | $ | — | $ | — | $ | — | $ | 50,784 | |||||||||||||||
Other expense, net | (10,940) | — | — | — | — | — | (10,940) | ||||||||||||||||||||||
Income from continuing operations before taxes | 30,311 | — | 9,533 | — | — | — | 39,844 | ||||||||||||||||||||||
Income tax expense (benefit) | 9,383 | — | 2,893 | — | — | (608) | 11,668 | ||||||||||||||||||||||
Net income from continuing operations | $ | 20,928 | $ | — | $ | 6,640 | $ | — | $ | — | $ | 608 | $ | 28,176 | |||||||||||||||
Diluted earnings per share from continuing operations* | $ | 0.23 | $ | — | $ | 0.07 | $ | — | $ | — | $ | 0.01 | $ | 0.30 | |||||||||||||||
Operating income from continuing operations as a % of sales | 2.9% | 3.6% | |||||||||||||||||||||||||||
Effective tax rate | 31.0% | 29.3% | |||||||||||||||||||||||||||
For the three months ended April 29, 2017 | GAAP | Transaction- |
Deal |
Intangible |
Integration |
Discrete |
Non- | ||||||||||||||||||||||
Operating income from continuing operations | $ | 96,155 | $ | 178 | $ | 9,745 | $ | — | $ | 257 | $ | — | $ | 106,335 | |||||||||||||||
Other expense, net | (10,368) | — | — | — | — | — | (10,368) | ||||||||||||||||||||||
Income from continuing operations before taxes | 85,787 | 178 | 9,745 | — | 257 | — | 95,967 | ||||||||||||||||||||||
Income tax expense (benefit) | 24,430 | 67 | 3,375 | — | 98 | 2,383 | 30,353 | ||||||||||||||||||||||
Net income from continuing operations | $ | 61,357 | $ | 111 | $ | 6,370 | $ | — | $ | 159 | $ | (2,383) | $ | 65,614 | |||||||||||||||
Diluted earnings per share from continuing operations* | $ | 0.65 | $ | — | $ | 0.07 | $ | — | $ | — | $ | (0.03) | $ | 0.69 | |||||||||||||||
Operating income from continuing operations as a % of sales | 6.7% | 7.4% | |||||||||||||||||||||||||||
Effective tax rate | 28.5% | 31.6% | |||||||||||||||||||||||||||
For the twelve months ended April 28, 2018 | GAAP |
Transaction- |
Deal |
Intangible |
Integration |
Discrete |
Non- | ||||||||||||||||||||||
Operating income from continuing operations | $ | 219,889 | $ | — | $ | 38,515 | $ | — | $ | 8,594 | $ | — | $ | 266,998 | |||||||||||||||
Other expense, net | (40,626) | — | — | — | — | — | (40,626) | ||||||||||||||||||||||
Income from continuing operations before taxes | 179,263 | — | 38,515 | — | 8,594 | — | 226,372 | ||||||||||||||||||||||
Income tax expense (benefit) | (21,711) | — | 11,793 | — | 2,879 | 76,648 | 69,609 | ||||||||||||||||||||||
Net income from continuing operations | $ | 200,974 | $ | — | $ | 26,722 | $ | — | $ | 5,715 | $ | (76,648) | $ | 156,763 | |||||||||||||||
Diluted earnings per share from continuing operations* | $ | 2.16 | $ | — | $ | 0.29 | $ | — | $ | 0.06 | $ | (0.82) | $ | 1.68 | |||||||||||||||
Operating income from continuing operations as a % of sales | 4.0% | 4.9% | |||||||||||||||||||||||||||
Effective tax rate | -12.1% | 30.7% | |||||||||||||||||||||||||||
For the twelve months ended April 29, 2017 | GAAP | Transaction- |
Deal |
Intangible |
Integration |
Discrete |
Non- | ||||||||||||||||||||||
Operating income from continuing operations | $ | 287,928 | $ | 1,657 | $ | 39,957 | $ | 36,312 | $ | 6,561 | $ | — | $ | 372,415 | |||||||||||||||
Other expense, net | (37,047) | — | — | — | — | — | (37,047) | ||||||||||||||||||||||
Income from continuing operations before taxes | 250,881 | 1,657 | 39,957 | 36,312 | 6,561 | — | 335,368 | ||||||||||||||||||||||
Income tax expense (benefit) | 77,093 | 625 | 13,769 | 13,263 | 2,481 | 4,789 | 112,020 | ||||||||||||||||||||||
Net income from continuing operations | $ | 173,788 | $ | 1,032 | $ | 26,188 | $ | 23,049 | $ | 4,080 | $ | (4,789) | $ | 223,348 | |||||||||||||||
Diluted earnings per share from continuing operations* | $ | 1.82 | $ | 0.01 | $ | 0.27 | $ | 0.24 | $ | 0.04 | $ | (0.05) | $ | 2.34 | |||||||||||||||
Operating income from continuing operations as a % of sales | 5.1% | 6.7% | |||||||||||||||||||||||||||
Effective tax rate | 30.7% | 33.4% | |||||||||||||||||||||||||||
* May not sum due to rounding | |||||||||||||||||||||||||||||
View source version on businesswire.com: https://www.businesswire.com/news/home/20180621005355/en/